Mary A Cifaldi

Title: Mary A. Cifaldi: Innovator in Rheumatoid Arthritis Treatment

Introduction

Mary A. Cifaldi is a notable inventor based in Gurnee, IL (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of rheumatoid arthritis. Her innovative work has led to the development of methods that enhance the efficacy of TNF-α inhibitors.

Latest Patents

Mary A. Cifaldi holds a patent for "Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis." This invention provides methods, uses, and compositions for treating rheumatoid arthritis. It describes the use of TNF-α inhibitors, such as human TNF-α antibodies, to improve treatment outcomes for patients suffering from this condition. Additionally, the patent outlines methods for determining the efficacy of these inhibitors in subjects.

Career Highlights

Mary is currently associated with AbbVie Biotechnology Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions for complex medical challenges.

Collaborations

Mary has collaborated with esteemed colleagues, including Hartmut Kupper and Jeffrey Kent, to further her research initiatives. These collaborations have enriched her work and contributed to the advancement of treatments in her field.

Conclusion

Mary A. Cifaldi's contributions to the treatment of rheumatoid arthritis through her innovative patent demonstrate her commitment to improving patient care. Her work continues to influence the biotechnology industry positively.